Investment Column: Norwich dangles a sizeable carrot
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Only a broken TV set or an extended holiday recently would have prevented Norwich Union members from being aware of the fact that they have until next Tuesday, 10 June, to apply for further shares in the mutual insurance group's pounds 2.4bn cash raising. Just to make sure, the group is pitching the shares being sold to its existing members, who are already receiving free handouts worth at least pounds 1,500, at a 25p discount to the price other shareholders, including the big institutions, will have to pay. With a strike price estimated at between 240p and 290p, that means members are being offered a discount of around 10 per cent, a sizeable carrot.
It is certainly an attractive deal, although because Norwich is choosing to raise fresh capital at the same time as its conversion to a publicly quoted company, institutions will not be quite so desperate as with Halifax and Alliance & Leicester to buy a meaningful weighting in the stock. That means the silly ratings applied to the building societies are unlikely to be repeated.
That said, Norwich Union is a well-regarded company, operating in a market that is bound to grow fast thanks to the steady unravelling of the welfare state. Its management has an improving reputation and there is still plenty of scope to cut costs. Most of the benefit of that process will now accrue to shareholders. Sales and profits from the UK life business are improving substantially, while the smaller general insurance arm has refocused on personal and small commercial lines and away from long tail policies and large risks. There is a strong healthcare business.
The dividend is well covered by life profits, so a gross yield at the flotation price of near to 5 per cent is both safe and attractive against the rest of the market. With a current "grey market" price of 305p, members should take up more shares, while the equity also looks reasonable value for outside investors.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments